Downregulation of Notch Pathway by a -Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model
Cancer Research - United States
doi 10.1158/0008-5472.can-09-3114
Full Text
Open PDFAbstract
Available in full text
Date
March 2, 2010
Authors
Publisher
American Association for Cancer Research (AACR)